Free Trial
→ Trump Orders 'National Digital Asset Stockpile' (From Crypto 101 Media) (Ad) Buy NLSPW Stock  Free NLSPW Stock Alerts

NLS Pharmaceutics (NLSPW) SEC Filings & 10K Form

NLS Pharmaceutics logo
$0.0045 0.00 (0.00%)
As of 04/17/2025
Compare

Recent NLS Pharmaceutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/15/2025
8:05 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
8:07 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
04/14/2025
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/31/2025
4:23 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
03/31/2025
9:24 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
03/31/2025
8:29 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:20 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:21 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
03/03/2025
5:40 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
02/27/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:02 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
02/14/2025
4:08 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:43 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
02/10/2025
6:57 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
02/10/2025
6:54 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
5:45 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/31/2025
6:47 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:51 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/30/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
9:46 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/28/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
4:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/16/2025
8:20 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
8:22 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/14/2025
3:27 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:04 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:14 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/07/2025
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:52 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:54 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/30/2024
5:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions  
12/23/2024
3:04 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
3:23 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K/A
12/19/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
7:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/17/2024
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/10/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K/A
12/03/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
BREAKING: Trump Bans NVIDIA Chips to China (Ad)

On April 16th, 2025, President Trump banned Nvidia from selling its most advanced semiconductors to China. That brings the U.S. and China closer to war than at any time since the Korean War ended in 1953.

There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K,
11/26/2024
11:15 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form EFFECT
11/21/2024
3:01 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/18/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
4:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
6:27 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/08/2024
3:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
3:30 PM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
11/05/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:39 PM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
YA II PN, Ltd. (Filed by)
Form SC 13G/A
11/04/2024
5:20 PM		Grisard Felix (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/04/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:02 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
10/28/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
3:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/22/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
4:19 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
10/18/2024
3:31 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
12:24 PM		ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G
10/15/2024
8:09 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
6:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
7:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
4:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/26/2024
3:40 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
8:16 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
07/01/2024
7:26 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 424B5
07/01/2024
7:09 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
3:54 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
11:15 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form EFFECT
06/25/2024
3:31 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
8:28 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
8:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
4:25 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
8:10 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
4:16 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NLSPW) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners
How War with China Could Start in 128 Days
The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...
Behind the Markets | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
Read before the next tariff announcement
Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...
Brownstone Research | Sponsored
🥾⛏️👷‍♂️ What I Learned From Numerous Mine Visits...
Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...
Golden Portfolio | Sponsored
Trump to unlock 15-figure fortune for America (May 3rd) ?
Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...
Paradigm Press | Sponsored
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored